UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

In Vitro Activity of OPT-80 Tested against Clinical Isolates of Toxin-Producing Clostridium difficile

Antimicrobial Agents and Chemotherapy, 2008-11, Vol.52 (11), p.4163-4165

2008

Volltextzugriff (PDF)

Fluoroquinolone-Resistant Urinary Isolates of Escherichia coli from Outpatients Are Frequently Multidrug Resistant: Results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance Study

Antimicrobial Agents and Chemotherapy, 2006-06, Vol.50 (6), p.2251-2254

2006

Volltextzugriff (PDF)

In Vitro Activity of Nemonoxacin, a Novel Nonfluorinated Quinolone, against 2,440 Clinical Isolates

Antimicrobial Agents and Chemotherapy, 2009-11, Vol.53 (11), p.4915-4920

2009

Volltextzugriff (PDF)

Molecular Characterization of Increasing Fluoroquinolone Resistance in Streptococcus pneumoniae Isolates in Canada, 1997 to 2005

Antimicrobial Agents and Chemotherapy, 2007-01, Vol.51 (1), p.198-207

2007

Volltextzugriff (PDF)

Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017

Journal of antimicrobial chemotherapy, 2020-07, Vol.75 (7), p.1824-1832

2020

Volltextzugriff (PDF)

Susceptibility of Clinical Isolates of Escherichia coli to Fosfomycin as Measured by Four In Vitro Testing Methods

Journal of clinical microbiology, 2020-09, Vol.58 (10)

2020

Volltextzugriff (PDF)

PCR ribotyping and antimicrobial susceptibility testing of isolates of Clostridium difficile cultured from toxin-positive diarrheal stools of patients receiving medical care in Canadian hospitals: the Canadian Clostridium difficile Surveillance Study (CAN-DIFF) 2013–2015

Diagnostic microbiology and infectious disease, 2018-06, Vol.91 (2), p.105-111

2018

Volltextzugriff (PDF)

In vitro susceptibility of urinary Escherichia coli isolates to first- and second-line empirically prescribed oral antimicrobials: CANWARD surveillance study results for Canadian outpatients, 2007–2016

International journal of antimicrobial agents, 2019-07, Vol.54 (1), p.62-68

2019

Volltextzugriff (PDF)

Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA)

International journal of antimicrobial agents, 2006-06, Vol.27 (6), p.468-475

2006

Volltextzugriff (PDF)

Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA)

International journal of antimicrobial agents, 2005-11, Vol.26 (5), p.380-388

2005

Volltextzugriff (PDF)

In vitro activity of API-1252, a novel FabI inhibitor, against clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis

Antimicrobial agents and chemotherapy, 2007-04, Vol.51 (4), p.1580-1581

2007

Volltextzugriff (PDF)

Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS)

Journal of antimicrobial chemotherapy, 2003-09, Vol.52 (3), p.382-388

2003

Volltextzugriff (PDF)

Molecular epidemiology of urinary tract isolates of vancomycin-resistant Enterococcus faecium from North America

International journal of antimicrobial agents, 2006-05, Vol.27 (5), p.392-396

2006

Volltextzugriff (PDF)

PCR ribotyping and antimicrobial susceptibility testing of isolates of Clostridium difficile cultured from toxin-positive diarrheal stools of patients receiving medical care in Canadian hospitals: the Canadian Clostridium icile Surveillance Study (CAN-DIFF) 2013–2015

Diagnostic microbiology and infectious disease, 2018-06, Vol.91 (2), p.105-111

2018

Volltextzugriff (PDF)

Fluoroquinolone-Resistant Urinary Isolates of Escherichia coli from Outpatients Are Frequently Multidrug Resistant: Results from the NorthAmerican Urinary Tract Infection Collaborative Alliance-QuinoloneResistance Study

Antimicrobial agents and chemotherapy, 2006-06, Vol.50 (6), p.2251-2254

2006

Volltextzugriff (PDF)

Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012

Vaccine, 2015-03, Vol.33 (13), p.1608-1613

2015

Volltextzugriff (PDF)

Acoustic detections and sightings of blue whales Balaenoptera musculus in the Seychelles, western tropical Indian Ocean (2020-2022)

Endangered species research, 2023-11, Vol.52, p.203-208

2023

Volltextzugriff (PDF)

A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV Infection

The Journal of infectious diseases, 2019-08, Vol.220 (6), p.990-1000

2019

Volltextzugriff (PDF)

The impact of horizontal violence on the individual nurse: A qualitative research study

Nurse education in practice, 2021-07, Vol.54, p.103079-103079, Article 103079

2021

Volltextzugriff (PDF)

Social Return on Investment: A New Approach to Understanding and Advocating for Value in Healthcare

The Journal of nursing administration, 2017-12, Vol.47 (12), p.623

2017

Volltextzugriff (PDF)

HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United States

Cancer epidemiology, biomarkers & prevention, 2015-02, Vol.24 (2), p.393-399

2015

Volltextzugriff (PDF)

Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008–2015

Clinical infectious diseases, 2019-04, Vol.68 (8), p.1282-1291

2019

Volltextzugriff (PDF)

Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006

Antimicrobial Agents and Chemotherapy, 2008-04, Vol.52 (4), p.1430-1437

2008

Volltextzugriff (PDF)

Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012

Emerging infectious diseases, 2015-09, Vol.21 (9), p.1557-1561

2015

Volltextzugriff (PDF)

Enduring Cell Lines: Parents’ Experiences of Postmortem Tumor Banking in Childhood Cancer

Journal of family nursing, 2021-11, Vol.27 (4), p.285-294

2021

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(53)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(46)
Humans
(38)
Female
(26)
Microbiology
(22)
Adult
(19)
Male
(19)
Biological And Medical Sciences
(17)
Infectious Diseases
(17)
Medical Sciences
(17)
Adolescent
(16)
Pharmacology & Pharmacy
(16)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(13)
Child
(13)
Middle Aged
(13)
Nursing
(13)
Pharmacology. Drug Treatments
(13)
Oncology
(11)
Microbial Sensitivity Tests
(10)
Neoplasms - Psychology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

In Vitro Activity of OPT-80 Tested against Clinical Isolates of Toxin-Producing Clostridium difficile

Fluoroquinolone-Resistant Urinary Isolates of Escherichia coli from Outpatients Are Frequently Multidrug Resistant: Results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance Study

In Vitro Activity of Nemonoxacin, a Novel Nonfluorinated Quinolone, against 2,440 Clinical Isolates

Molecular Characterization of Increasing Fluoroquinolone Resistance in Streptococcus pneumoniae Isolates in Canada, 1997 to 2005

Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017

Susceptibility of Clinical Isolates of Escherichia coli to Fosfomycin as Measured by Four In Vitro Testing Methods

PCR ribotyping and antimicrobial susceptibility testing of isolates of Clostridium difficile cultured from toxin-positive diarrheal stools of patients receiving medical care in Canadian hospitals: the Canadian Clostridium difficile Surveillance Study (CAN-DIFF) 2013–2015

In vitro susceptibility of urinary Escherichia coli isolates to first- and second-line empirically prescribed oral antimicrobials: CANWARD surveillance study results for Canadian outpatients, 2007–2016

Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA)

Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA)

In vitro activity of API-1252, a novel FabI inhibitor, against clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis

Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS)

Molecular epidemiology of urinary tract isolates of vancomycin-resistant Enterococcus faecium from North America

PCR ribotyping and antimicrobial susceptibility testing of isolates of Clostridium difficile cultured from toxin-positive diarrheal stools of patients receiving medical care in Canadian hospitals: the Canadian Clostridium icile Surveillance Study (CAN-DIFF) 2013–2015

Fluoroquinolone-Resistant Urinary Isolates of Escherichia coli from Outpatients Are Frequently Multidrug Resistant: Results from the NorthAmerican Urinary Tract Infection Collaborative Alliance-QuinoloneResistance Study

Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012

Acoustic detections and sightings of blue whales Balaenoptera musculus in the Seychelles, western tropical Indian Ocean (2020-2022)

A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV Infection

The impact of horizontal violence on the individual nurse: A qualitative research study

Social Return on Investment: A New Approach to Understanding and Advocating for Value in Healthcare

HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United States

Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008–2015

Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006

Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012

Enduring Cell Lines: Parents’ Experiences of Postmortem Tumor Banking in Childhood Cancer

Suchergebnisse filtern